Medindia
Medindia LOGIN REGISTER
Advertisement

Due to Generic Erosion, the Hypertension Drug Market Will Decline by $3 Billion from 2009 to 2019

Tuesday, September 28, 2010 Hypertension News
Advertisement
Novartis's Diovan/Tareg Will Suffer the Greatest Decline As Its Sales Will Decrease More Than $1 Billion in 2013, According to Findings from Decision Resources

For more information, contact:

Decision Resources, Inc.

Christopher Comfort

781-993-2597

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on Hypertension News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close